Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
84,113,039
-
Share change
-
-1,307,397
-
Total reported value
-
$3,255,240,619
-
Put/Call ratio
-
124%
-
Price per share
-
$38.70
-
Number of holders
-
217
-
Value change
-
-$79,497,227
-
Number of buys
-
111
-
Number of sells
-
109
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2016
As of 31 Dec 2016 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 84,113,039 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, Invesco Ltd., FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This table shows 217 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.